BioCryst Pharmaceuticals Has Returned 10.3% Since SmarTrend Recommendation (BCRX)

SmarTrend identified a Downtrend for BioCryst Pharmaceuticals (NASDAQ:BCRX) on September 28th, 2015 at $10.96. In approximately 2 months, BioCryst Pharmaceuticals has returned 10.31% as of today's recent price of...